Log In
Print this Print this

AQS-1301, AQS1301

  Manage Alerts
Collapse Summary General Information
Company Aequus Pharmaceuticals Inc.
DescriptionOnce-weekly transdermal patch formulation of aripiprazole, a small molecule partial agonist of the dopamine D2 and serotonin (5-HT1A) receptors and antagonist of the 5-HT2A receptor
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT1A) receptor
Mechanism of ActionDopamine D2 receptor agonist; Serotonin (5-HT) receptor agonist; Serotonin (5-HT2A) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today